This case study highlights GSK’s pilot of PAS 2090. It demonstrates how harmonised carbon measurement improves data quality, identifies emission hotspots, and strengthens supply chain transparency.
Suggested region and language based on your location
Your current region and language
GSK, a global biopharma company, selected an oncology therapy for this case study to test the practical application of PAS 2090.
“PAS 2090 provides the consistency & transparency that health systems need to help decarbonise care, providing framework to reduce product footprints.”
This case study highlights GSK’s pilot of PAS 2090. It demonstrates how harmonised carbon measurement improves data quality, identifies emission hotspots, and strengthens supply chain transparency.
Reach out and see how we can help guide you on your path to sustainable operational success.